325 related articles for article (PubMed ID: 11287448)
21. Cigarette smoking and subtypes of bladder cancer.
Jiang X; Castelao JE; Yuan JM; Stern MC; Conti DV; Cortessis VK; Pike MC; Gago-Dominguez M
Int J Cancer; 2012 Feb; 130(4):896-901. PubMed ID: 21412765
[TBL] [Abstract][Full Text] [Related]
22. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
[TBL] [Abstract][Full Text] [Related]
23. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
24. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).
Zeegers MP; Goldbohm RA; van den Brandt PA
Cancer Causes Control; 2002 Feb; 13(1):83-90. PubMed ID: 11899922
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study.
Momas I; Daures JP; Festy B; Bontoux J; Gremy F
Eur J Epidemiol; 1994 Oct; 10(5):599-604. PubMed ID: 7859861
[TBL] [Abstract][Full Text] [Related]
26. Phenobarbital use and bladder cancer risk.
Castelao JE; Gago-Dominguez M; Yuan JM; Ross RK; Yu MC
Eur J Epidemiol; 2003; 18(7):659-64. PubMed ID: 12952139
[TBL] [Abstract][Full Text] [Related]
27. An international study of smoking and bladder cancer.
Morrison AS; Buring JE; Verhoek WG; Aoki K; Leck I; Ohno Y; Obata K
J Urol; 1984 Apr; 131(4):650-4. PubMed ID: 6708176
[TBL] [Abstract][Full Text] [Related]
28. Differences in lung cancer risk between men and women: examination of the evidence.
Zang EA; Wynder EL
J Natl Cancer Inst; 1996 Feb; 88(3-4):183-92. PubMed ID: 8632492
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking and bladder cancer.
D'Avanzo B; Negri E; La Vecchia C; Gramenzi A; Bianchi C; Franceschi S; Boyle P
Eur J Cancer; 1990; 26(6):714-8. PubMed ID: 2144159
[TBL] [Abstract][Full Text] [Related]
30. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
31. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies.
Brennan P; Bogillot O; Cordier S; Greiser E; Schill W; Vineis P; Lopez-Abente G; Tzonou A; Chang-Claude J; Bolm-Audorff U; Jöckel KH; Donato F; Serra C; Wahrendorf J; Hours M; T'Mannetje A; Kogevinas M; Boffetta P
Int J Cancer; 2000 Apr; 86(2):289-94. PubMed ID: 10738259
[TBL] [Abstract][Full Text] [Related]
33. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9788-91. PubMed ID: 3200858
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking.
Bedwani R; el-Khwsky F; Renganathan E; Braga C; Abu Seif HH; Abul Azm T; Zaki A; Franceschi S; Boffetta P; La Vecchia C
Int J Cancer; 1997 Sep; 73(1):64-7. PubMed ID: 9334811
[TBL] [Abstract][Full Text] [Related]
35. The contribution of cigarette smoking to bladder cancer in women (pooled European data).
Brennan P; Bogillot O; Greiser E; Chang-Claude J; Wahrendorf J; Cordier S; Jöckel KH; Lopez-Abente G; Tzonou A; Vineis P; Donato F; Hours M; Serra C; Bolm-Audorff U; Schill W; Kogevinas M; Boffetta P
Cancer Causes Control; 2001 Jun; 12(5):411-7. PubMed ID: 11545456
[TBL] [Abstract][Full Text] [Related]
36. The use of biomarkers in epidemiology: the example of bladder cancer.
Vineis P
Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
[TBL] [Abstract][Full Text] [Related]
37. Smoking and bladder cancer. The modifying effect of cigarettes on other factors.
Slattery ML; Schumacher MC; West DW; Robison LM
Cancer; 1988 Jan; 61(2):402-8. PubMed ID: 3334975
[TBL] [Abstract][Full Text] [Related]
38. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
[TBL] [Abstract][Full Text] [Related]
39. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women.
Puente D; Hartge P; Greiser E; Cantor KP; King WD; González CA; Cordier S; Vineis P; Lynge E; Chang-Claude J; Porru S; Tzonou A; Jöckel KH; Serra C; Hours M; Lynch CF; Ranft U; Wahrendorf J; Silverman D; Fernandez F; Boffetta P; Kogevinas M
Cancer Causes Control; 2006 Feb; 17(1):71-9. PubMed ID: 16411055
[TBL] [Abstract][Full Text] [Related]
40. [Impact of cigarette packages warning labels in relation to tobacco-smoking dependence and motivation to quit].
Mannocci A; Antici D; Boccia A; La Torre G
Epidemiol Prev; 2012; 36(2):100-7. PubMed ID: 22706360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
